Contact Information
Company Information
Annual Revenue
78000000.0
Professional Summary
Justin To serves as CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio. BridgeBio operates in the research sector with approximately 750.0 employees. The company is headquartered in San Francisco, California. BridgeBio generates annual revenue of 78000000.0.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
We have verified contacts for 8 executives at BridgeBio.
-
•
13,743 executive contacts are available in California.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Salesforce
Outlook
Microsoft Office 365
Zendesk
Gmail
Google Apps
VueJS
Atlassian Cloud
Zapier
Vercel
Marketo
Hubspot
Google Analytics
WordPress.org
Akamai RUM
Google Font API
New Relic
Mobile Friendly
Google Tag Manager
YouTube
Remote
Phoenix
AI
Node.js
Android
Python
SharePoint
Flutter
IoT
Keywords
biotechnology: pharmaceutical preparations
health care
biotechnology research
biopharmaceutical
genetic diseases
transformative medicines
drug development
clinical trials
orphan drugs
gene therapy
small molecule
fda approval
pipeline
molecular biology
biotechnology
patient-centric
rare diseases
innovative therapies
genetic mutations
clinical research
healthcare partnerships
patient access
therapeutic technologies
advanced clinical trials
competitive landscape
scientific innovation
drug discovery
market access
patient advocacy
regulatory affairs
genomic medicine
therapeutic development
pharmaceutical collaborations
genetic research
clinical development
early-stage research
biotech company
patient solutions
preclinical studies
genetic targets
discovery platform
commercial infrastructure
healthcare collaboration
research capabilities
accelerated approval
biostatistics
molecular targets
drug candidates
market opportunity
therapeutic areas
regenerative medicine
healthcare investors
therapeutic pipeline
biopharmaceuticals
precision oncology
genetic drivers
mendelian diseases
genome sequencing
targeted therapies
decentralized model
innovative science
patient engagement
oncology therapeutics
genetic dermatology
cardiology
neurology
endocrinology
pulmonology
renal disease
approved therapies
drug pipeline
patient needs
radical transparency
entrepreneurial agility
strategic partnerships
healthcare professionals
regulatory compliance
unmet medical needs
rare pediatric diseases
clinical trial execution
safety profile optimization
health
wellness & fitness
hospital & health care
medical
Related Executives
Outreach Guidance — research Sector
Executives like Justin To in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at BridgeBio.
Frequently Asked Questions
How do I reach Justin To directly?
Justin To's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Justin To work for?
Justin To is CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio, a company in the research sector with 750.0 employees. The company is based in San Francisco, California.
Can I pitch or sell to Justin To?
As CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio, Justin To is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Justin To directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Justin To in?
Justin To works in the research industry as CEO, Skeletal Dysplasias (QED Therapeutics) at BridgeBio. MessageCEO provides verified contact information for executives across all major industries.
Is Justin To's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Justin To's profile is kept up-to-date with the latest available information.
Last updated: May 10, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans